Conning Inc. Has $32.36 Million Holdings in Cigna Group $CI

Posted by Brian Himes on May 15th, 2026

Conning Inc. lifted its position in Cigna Group (NYSE:CI – Free Report) by 12.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 117,583 shares of the health services provider’s stock after buying an additional 13,115 shares during the quarter. Conning Inc.’s holdings in Cigna Group were worth $32,362,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. OLD National Bancorp IN increased its stake in shares of Cigna Group by 3.7% during the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after purchasing an additional 37 shares during the last quarter. Leavell Investment Management Inc. lifted its stake in Cigna Group by 3.8% in the 3rd quarter. Leavell Investment Management Inc. now owns 1,103 shares of the health services provider’s stock valued at $318,000 after purchasing an additional 40 shares during the last quarter. Physician Wealth Advisors Inc. grew its holdings in Cigna Group by 1.5% during the third quarter. Physician Wealth Advisors Inc. now owns 2,712 shares of the health services provider’s stock worth $782,000 after purchasing an additional 41 shares during the period. Cookson Peirce & Co. Inc. grew its holdings in Cigna Group by 0.8% during the third quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock worth $1,428,000 after purchasing an additional 41 shares during the period. Finally, Signet Financial Management LLC increased its position in Cigna Group by 0.6% during the third quarter. Signet Financial Management LLC now owns 7,459 shares of the health services provider’s stock worth $2,150,000 after buying an additional 41 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on CI shares. Piper Sandler reduced their target price on Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Mizuho set a $330.00 price target on Cigna Group in a report on Friday, May 1st. TD Cowen upped their price objective on shares of Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a report on Monday, February 9th. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Finally, Cantor Fitzgerald lifted their target price on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $338.35.

Get Our Latest Analysis on Cigna Group

Insiders Place Their Bets

In related news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 205,904 shares of company stock worth $60,277,068 in the last quarter. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Stock Down 2.1%

CI stock opened at $294.39 on Friday. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market capitalization of $77.87 billion, a price-to-earnings ratio of 12.48, a PEG ratio of 1.05 and a beta of 0.30. The business’s fifty day moving average price is $274.94 and its two-hundred day moving average price is $275.90.

Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter in the previous year, the business posted $6.74 earnings per share. Cigna Group’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities analysts anticipate that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is presently 26.45%.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.